EMA — authorised 22 November 2021
- Marketing authorisation holder: AMIVAS IRELAND LTD
- Status: approved
EMA authorised Artesunate on 22 November 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 22 November 2021.
AMIVAS IRELAND LTD holds the EU marketing authorisation.